{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T20:29:20Z","timestamp":1778531360581,"version":"3.51.4"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2,3]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The prognosis of lung cancer is related to the stage of the disease at the time of detection, and early diagnosis can prolong survival time. In this prospective observational cohort research, we aimed to analyze the diagnostic performance of the combined application of ACSL4 and low-dose 256-slice spiral computed tomography (CT) to lung cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This prospective observational cohort research enrolled a total of 512 patients with pulmonary nodules (PN) who were found with PN by CT. All patients were divided into 2 groups through biopsy operation, including 449 patients with benign PN and 63 patients with malignant PN. Both groups were scanned with a Philips Brilliance 256iCT machine. Imaging features of PN were recorded. All images of the nodules were used for data measurement and image analysis by the Lung Nodule Assessment analysis software. The serum ACSL4, carcinoembryonic antigen (CEA), cytokeratin 19 fragment 21-1 (CYFRA21-1), neuron-specific enolase, carbohydrate antigen 199 (CA199) and carbohydrate antigen 125 (CA125) levels were measured by enzyme-linked immunosorbent assay method. The demographic data and clinical data, including age, sex, body mass index, smoke condition, TNM stage, lymph node metastasis and distant metastasis were collected. All the patients were followed for 5 years. Statistical analysis was conducted using SPSS software with <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05 as statistically different.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The diameter of nodules, the proportion of burr signs and smoking status, and the serum levels of CEA, CYFRA21-1, CA199, CA125 were significantly higher in malignant nodules group compared with the benign nodules group. Serum ACSL4 levels of malignant nodules group (19.33\u2005\u00b1\u20056.92\u2009ng\/mL) were remarkably lower than the benign nodules group (25.34\u2005\u00b1\u20053.78\u2009ng\/mL). ACSL4 was negatively correlated with CEA, CYFRA21-1, CA199, and CA125. ACSL4 was associated with the clinical outcomes in malignant PN patients and lower ACSL4 predicted poor clinic outcomes and prognosis. In addition, ACSL4 combined with low-dose 256-slice spiral CT had satisfactory diagnostic value for lung cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>In summary, our results showed that combination application of ACSL4 and low-dose 256-slice spiral CT might be a potential method for the early screening of lung cancer.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000032733","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T15:13:33Z","timestamp":1675782813000},"page":"e32733","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Combination of serum ACSL4 levels and low-dose 256-slice spiral CT exhibits the potential in the early screening of lung cancer"],"prefix":"10.1097","volume":"102","author":[{"given":"Wenlong","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Ultrasound, The Third Affiliated Hospital of Qiqihar Medical University, Qiqihar, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[{"name":"Diagnostic Radiology Center, The Third Affiliated Hospital of Qiqihar Medical University, Qiqihar, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of General Surgery and Central Laboratory, The Third Affiliated Hospital of Qiqihar Medical University, Qiqihar, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Third Affiliated Hospital of Qiqihar Medical University, Qiqihar, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuying","family":"Wang","sequence":"additional","affiliation":[{"name":"Diagnostic Radiology Center, The Third Affiliated Hospital of Qiqihar Medical University, Qiqihar, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9758-0915","authenticated-orcid":false,"given":"Xuejia","family":"Sun","sequence":"additional","affiliation":[{"name":"Diagnostic Radiology Center, The Third Affiliated Hospital of Qiqihar Medical University, Qiqihar, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018.","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5334\/aogh.2419","article-title":"Global epidemiology of lung cancer.","volume":"85","author":"Barta","year":"2019","journal-title":"Ann Global Health"},{"key":"R4-20250504","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-24932-2_6","article-title":"Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management.","volume":"890","author":"Ahmad","year":"2016","journal-title":"Preface. Adv Exp Med Biol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"330","DOI":"10.7326\/M13-2771","article-title":"Screening for lung cancer: US Preventive Services Task Force recommendation statement.","volume":"160","author":"Moyer","year":"2014","journal-title":"Ann Intern Med"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"515","DOI":"10.6004\/jnccn.2015.0071","article-title":"Non\u2013small cell lung cancer, version 6.2015.","volume":"13","author":"Ettinger","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1258\/jms.2011.011055","article-title":"Lung cancer screening with low-dose helical CT: results from the National Lung Screening Trial (NLST).","volume":"18","author":"Kramer","year":"2011","journal-title":"J Med Screen"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/S1470-2045(14)70389-4","article-title":"Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.","volume":"15","author":"Horeweg","year":"2014","journal-title":"Lancet Oncol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening.","volume":"365","year":"2011","journal-title":"N Engl J Med"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.3390\/ijms20153624","article-title":"Targeting long chain acyl-coa synthetases for cancer therapy.","volume":"20","author":"Rossi Sebastiano","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R11-20250504","first-page":"8429","article-title":"Fatty acid CoA ligase 4 is up-regulated in colon adenocarcinoma.","volume":"61","author":"Cao","year":"2001","journal-title":"Cancer Res"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcmgh.2017.05.004","article-title":"Identification of the consistently altered metabolic targets in human hepatocellular carcinoma.","volume":"4","author":"Nwosu","year":"2017","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"R13-20250504","first-page":"e77060e77060","article-title":"Long chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancer.","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13062-020-00284-1","article-title":"High-fat diet impairs ferroptosis and promotes cancer invasiveness via downregulating tumor suppressor ACSL4 in lung adenocarcinoma.","volume":"16","author":"Zhang","year":"2021","journal-title":"Biol Direct"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1056\/NEJMoa1214726","article-title":"Probability of cancer in pulmonary nodules detected on first screening CT.","volume":"369","author":"McWilliams","year":"2013","journal-title":"N Engl J Med"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccm.2019.10.001","article-title":"Lung cancer 2020: epidemiology, etiology, and prevention.","volume":"41","author":"Bade","year":"2020","journal-title":"Clin Chest Med"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/crj.12572","article-title":"Diagnostic investigation of BIRC 6 and SIRT 1 protein expression level as potential prognostic biomarkers in patients with non-small cell lung cancer.","volume":"12","author":"Gharabaghi","year":"2018","journal-title":"Clin Resp J"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1111\/febs.14132","article-title":"hsa_circ_0013958: a circular RNA and potential novel biomarker for lung adenocarcinoma.","volume":"284","author":"Zhu","year":"2017","journal-title":"FEBS J"},{"key":"R19-20250504","first-page":"2607","article-title":"Clinical significance of circulatory miRNA-21 as an efficient non-invasive biomarker for the screening of lung cancer patients.","volume":"19","author":"Abu-Duhier","year":"2018","journal-title":"Asian Pac J Cancer Prev"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.lungcan.2011.11.012","article-title":"Carcinoembryonic antigen (CEA) as tumor marker in lung cancer.","volume":"76","author":"Grunnet","year":"2012","journal-title":"Lung Cancer"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000181180","article-title":"Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as tumor markers in patients with lung cancer: comparison with CYFRA 21-1, CEA, SCC and NSE.","volume":"29","author":"Molina","year":"2008","journal-title":"Tumor Biol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.lungcan.2013.01.002","article-title":"Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer.","volume":"80","author":"Okamura","year":"2013","journal-title":"Lung Cancer"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/iub.1486","article-title":"Tumor\u2010suppressive functions of long\u2010chain acyl\u2010CoA synthetase 4 in gastric cancer.","volume":"68","author":"Ye","year":"2016","journal-title":"IUBMB Life"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bbrc.2021.01.028","article-title":"Oleanolic acid inhibits cervical cancer Hela cell proliferation through modulation of the ACSL4 ferroptosis signaling pathway.","volume":"545","author":"Xiaofei","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"103560","DOI":"10.1016\/j.ebiom.2021.103560","article-title":"Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy.","volume":"71","author":"Sha","year":"2021","journal-title":"EBioMedicine"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.thorsurg.2014.12.003","article-title":"National Comprehensive Cancer Network (NCCN) clinical practice guidelines for lung cancer screening.","volume":"25","author":"Wood","year":"2015","journal-title":"Thorac Surg Clin"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"dju284","DOI":"10.1093\/jnci\/dju284","article-title":"Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination.","volume":"106","author":"Gierada","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12957-017-1171-y","article-title":"Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study.","volume":"15","author":"Li","year":"2017","journal-title":"World J Surg Oncol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-020-0863-y","article-title":"A miRNA-based diagnostic model predicts resectable lung cancer in humans with high accuracy.","volume":"3","author":"Asakura","year":"2020","journal-title":"Commun Biol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"106381","DOI":"10.1016\/j.cmpb.2021.106381","article-title":"Fusion of 3D lung CT and serum biomarkers for diagnosis of multiple pathological types on pulmonary nodules.","volume":"210","author":"Fu","year":"2021","journal-title":"Comput Methods Programs Biomed"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12291-012-0257-0","article-title":"Diagnostic role of tumour markers CEA, CA15-3, CA19-9 and CA125 in lung cancer.","volume":"28","author":"Ghosh","year":"2013","journal-title":"Indian J Clin Biochem"},{"key":"R32-20250504","first-page":"832","article-title":"[Clinical value of combined detection of serum tumor markers in lung cancer diagnosis].","volume":"39","author":"Chen","year":"2008","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"18850873","DOI":"10.1155\/2020\/8850873","article-title":"The combination of CA125 and NSE is useful for predicting liver metastasis of lung cancer.","volume":"2020","author":"Wang","year":"2020","journal-title":"Dis Markers"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032733","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:43:42Z","timestamp":1746326622000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,3]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000032733","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,3]]}}}